Skip to content

Medical emergency? What to do

Marker of aggressive prostate cancer identified

3-RXPublished September 3, 20072 min read

Key points

  • Researchers at the Mayo Clinic in Rochester, Minnesota, have identified a protein "biomarker" of aggressive prostate cancer.
  • In the journal Cancer Research, Roth and colleagues report that normal prostate cells express low levels of B7-H3, but levels of the protein are increased in prostate cancer cells, particularly prostate cancer cells with aggressive features.
  • B7-H3 expression was "typically low" within normal prostate glands, the team reports, but was aberrantly expressed in prostate tumors.
  • During follow up, patients with high levels of B7-H3 were significantly more likely to progress than patients with low levels of B7-H3 in their tumors.

Researchers at the Mayo Clinic in Rochester, Minnesota, have identified a protein "biomarker" of aggressive prostate cancer. The protein, known as B7-H3, plays a role in the functioning of the immune system.

Based on their studies to date, Dr. Timothy J. Roth and associates believe that B7-H3 is a promising marker that may eventually help doctors better diagnose prostate cancer and assess prognosis. It may also represent a good target for new prostate cancer drugs.

In the journal Cancer Research, Roth and colleagues report that normal prostate cells express low levels of B7-H3, but levels of the protein are increased in prostate cancer cells, particularly prostate cancer cells with aggressive features.

Roth's team tested preserved prostate tissue from 338 men with prostate cancer who had their prostates removed between 1995 and 1998. All of the prostate tumors had evidence of B7-H3. B7-H3 was also found in normal prostate tissue, but in lower amounts than that seen in tumor tissue.

B7-H3 expression was "typically low" within normal prostate glands, the team reports, but was aberrantly expressed in prostate tumors.

The level of B7-H3 was significantly associated with larger tumors and tumors that had spread beyond the prostate, the authors report. In analyses adjusted for factors that might influence prognosis, B7-H3 remained a statistically significant predictor of prostate cancer progression.

During follow up, patients with high levels of B7-H3 were significantly more likely to progress than patients with low levels of B7-H3 in their tumors. Furthermore, survival at 5 years after surgery without tumor progression was roughly 92 percent in patients with low levels of B7-H3, 86 percent in those with moderate levels and 55 percent in those with high B7-H3 levels.

SOURCE: Cancer Research, August 15, 2007.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underProstate Cancer

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.